0001213900-25-002064.txt : 20250108 0001213900-25-002064.hdr.sgml : 20250108 20250108160021 ACCESSION NUMBER: 0001213900-25-002064 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250108 DATE AS OF CHANGE: 20250108 EFFECTIVENESS DATE: 20250108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nukkleus Inc. CENTRAL INDEX KEY: 0001787518 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 383912845 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-534609 FILM NUMBER: 25518498 BUSINESS ADDRESS: STREET 1: 525 WASHINGTON BLVD CITY: JERSEY CITY STATE: NJ ZIP: 07310 BUSINESS PHONE: 212-791-4663 MAIL ADDRESS: STREET 1: 525 WASHINGTON BLVD CITY: JERSEY CITY STATE: NJ ZIP: 07310 FORMER COMPANY: FORMER CONFORMED NAME: Brilliant Acquisition Corp DATE OF NAME CHANGE: 20190909 D 1 primary_doc.xml X0708 D LIVE 0001787518 Nukkleus Inc. 525 WASHINGTON BLVD. JERSEY CITY NJ NEW JERSEY 07310 212-791-4663 DELAWARE Brilliant Acquisition Corp. Brilliant Acquisition Corp Corporation true 2023 Menachem Shalom 295 E. Renfro, Suite 209 Jersey City NJ NEW JERSEY 07310 Executive Officer Director David Rokach 295 E. Renfro, Suite 209 Jersey City NJ NEW JERSEY 07310 Director Tomer Nagar 295 E. Renfro, Suite 209 Jersey City NJ NEW JERSEY 07310 Director Aviya Volodarsky 295 E. Renfro, Suite 209 Jersey City NJ NEW JERSEY 07310 Director Reuven Yeganeh 295 E. Renfro, Suite 209 Jersey City NJ NEW JERSEY 07310 Director Anastasiia Kotaieva 295 E. Renfro, Suite 209 Jersey City NJ NEW JERSEY 07310 Director Other Decline to Disclose 06b false 2024-12-20 false true Units consisting of shares of common stock, common stock purchase warrant and pre-funded common stock purchase warrant false 0 Dawson James Securities Inc. 000130645 None None 101 North Federal Hwy. Suite 600 Boca Raton FL FLORIDA 33432 NY NEW YORK false 10000000 10000000 0 false 1 700000 0 Proceeds will be used for executive salaries. Proceeds to be used for an acquisition and used for working capital of acquisition. The Company's CEO, is CEO, director and shareholder of acquisition but amounts have not been included in the estimate. 240000 true Proceeds will be used for executive salaries. Proceeds to be used for an acquisition for working capital of target. The Company's CEO is affiliate of acquisition but amounts have not been included in the estimate. false Nukkleus Inc. /s/ Menachem Shalom Menachem Shalom Chief Executive Officer 2025-01-06